Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in IOVA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,222,994
+$464,820 QoQ
Shares Held
293,989
+36.1% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 292 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Derivatives in IOVA

reported options exposure · as of Jun 30, 2026
CallValue
$208,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. IOVA ranks #48 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IOVA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $208,000 50,000
2026-06-30 $1,222,994 293,989
2026-03-31 $758,174 216,004
2025-12-31 $490,018 179,494
2025-09-30 $264,184 121,744
2025-03-31 $409,356 122,930
2024-09-30 $2,055,724 218,927
2024-06-30 $2,405,077 299,885
2024-03-31 $3,625,209 244,616
2023-12-31 $269,493 33,148
2023-06-30 $811,550 115,277
2023-03-31 $351,489 57,527
2022-12-31 $604,679 94,629
2022-09-30 $754,712 78,780
2022-06-30 $999,053 90,494
2022-03-31 $505,660 30,370
2021-12-31 $1,670,985 87,532
2021-09-30 $1,183,236 47,982
2021-03-31 $4,751,881 150,091
2020-06-30 $876,698 31,938